Therapeutics Acquisition Corp.
NASDAQ: RACA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Peter Kolchinsky
- Headquarters
- Boston, United States
- IPO year
- 2020
- Market cap
- $1.1B
- Website
- http://www.researchalliancecorp.com
Loading RACA…
Loading profile data…Frequently asked questions about RACA
What does Therapeutics Acquisition Corp. (RACA) do?
Therapeutics Acquisition Corp., which operates as Research Alliance Corp. I, was founded in 2020 and is headquartered in Boston, Massachusetts. Its core mission is to pursue a business combination, including but not limited to mergers, capital stock exchanges, asset acquisitions, share purchases, or reorganizations, with one or more enterprises...
Where does RACA trade?
Therapeutics Acquisition Corp. (RACA) trades on the NASDAQ Capital Market.
What sector is RACA in?
Therapeutics Acquisition Corp. (RACA) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Therapeutics Acquisition Corp.?
Peter Kolchinsky is the chief executive officer of Therapeutics Acquisition Corp. (RACA).
Where is Therapeutics Acquisition Corp. headquartered?
Therapeutics Acquisition Corp. is headquartered in United States.
Does RACA pay a dividend?
Therapeutics Acquisition Corp. (RACA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RACA go public?
Therapeutics Acquisition Corp. (RACA) completed its initial public offering in 2020.